Future Directions For GLP-1 Receptor Agonists Judging from the current research and development trends, long-acting, oral dosage forms and multi-target receptor agonists are the key directions for the future development of GLP-1 receptor agonists
Studies suggest that NAC may enhance the elimination of mycotoxins from the body, reducing their toxic burden
10.1016/j.molmet.2022.101549 55 EnersonB
You should also talk to your clinician promptly if you develop: Persistent right-sided upper abdominal pain, nausea after fatty meals, or pain radiating to the back or shoulder (possible gallbladder involvement) Ongoing vomiting, inability to tolerate normal portions, or symptoms consistent with significant delayed gastric emptying If your clinician suspects gastroparesis risk, they may recommend a different medication strategy, a slower titration, additional testing, or a pause
References Goodman & Gilmans The Pharmacological Basis of Therapeutics Katzung Basic and Clinical Pharmacology Clinical trials data on linagliptin efficacy and safety